Neuronetics (STIM) Operating Margin Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 3,764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,764.00 |
| Dec 31, 2025 | 3,039.00 |
| Sep 30, 2025 | 2,555.00 |
| Jun 30, 2025 | 3,885.00 |
| Mar 31, 2025 | 3,702.00 |
| Dec 31, 2024 | -501.00 |
| Sep 30, 2024 | 1,034.00 |
| Jun 30, 2024 | -550.00 |
| Mar 31, 2024 | 1,684.00 |
| Dec 31, 2023 | -472.00 |
| Sep 30, 2023 | -3,013.00 |
| Jun 30, 2023 | 2,868.00 |
| Mar 31, 2023 | 2,658.00 |
| Dec 31, 2022 | -248.00 |
| Sep 30, 2022 | -563.00 |
| Jun 30, 2022 | -2,012.00 |
| Mar 31, 2022 | -1,603.00 |
| Dec 31, 2021 | -979.00 |
| Sep 30, 2021 | -2,051.00 |
| Jun 30, 2021 | -670.00 |
| Mar 31, 2021 | -1,087.00 |
| Dec 31, 2020 | 1,789.00 |
| Sep 30, 2020 | 731.00 |
| Jun 30, 2020 | -4,541.00 |
| Mar 31, 2020 | -3,734.00 |